Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
C4x Discovery Holdings Plc LSE:C4XD London Ordinary Share GB00BQQ2RV18 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.05 -0.29% 17.35 17.20 17.50 18.00 17.25 18.00 36,402 16:35:22
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -5.9 -2.0 - 44

C4x Discovery Share Discussion Threads

Showing 2726 to 2746 of 2850 messages
Chat Pages: 114  113  112  111  110  109  108  107  106  105  104  103  Older
DateSubjectAuthorDiscuss
28/1/2022
10:22
Looking good boys
bloomberg2
24/1/2022
18:04
Savvy investors will start picking up cheap stock now - whoever "managed" this sale over the last week or so doesnt have a clue. They have smashed a share price and set the rumour mill going again.
alloa2003
24/1/2022
16:16
Did you buy the dippy dip dip ?
bloomberg2
24/1/2022
16:15
https://twitter.com/rckhlld/status/1485646362842644480?s=21
bloomberg2
24/1/2022
14:38
In freefall at the minute - time for the brave to buy,
alloa2003
21/1/2022
08:24
Under a bit of pressure today - looks like a badly handled sale order over the last few days to me.
alloa2003
04/1/2022
19:26
This one is slipping under a lot of radars - potential long term cash cow if one or more of the current (not to mention future) molecule treatments come off. Aside from the HUGE stage payments if/when they get to market, long term royalties seem to have been overlooked by many.
alloa2003
21/12/2021
22:59
Check this interview from 5 minutes in:-

https://www.proactiveinvestors.co.uk/companies/news/969016/c4x-discovery-holdings-highlight-their-good-position-for-advancement-and-expansion-in-current-year-969016.html

Interested to hear feedback.

alloa2003
21/12/2021
22:57
He seems ultra-positive to me!
alloa2003
21/12/2021
10:51
https://www.proactiveinvestors.co.uk/companies/news/969838/c4x-discovery-holdings-appoints-chief-scientific-officer-969838.html
charlie9038
21/12/2021
10:38
Where did you read that comment alloa.....Imissed that but it is certainly interesting.
bamboozler
21/12/2021
07:55
They dont hang around:-

21 December 2021 - C4X Discovery Holdings plc (AIM: C4XD), a pioneering Drug Discovery company, today announces the appointment of Dr Catherine Jane Tralau-Stewart, PhD, FRSC, as Chief Scientific Officer ("CSO"), as of 4 January 2022.

This lady seems to have the perfect track record to assist in developing C4XD. All of the pieces of the jigsaw are falling into place. If you read Clive Dix comments, he mentions they are looking at DNA related treatments now because they will soon have the current portfolio of molecules commercialised. Interesting stuff!

Remember, royalty payments are on top of milestone payments and would turn this into a cash cow if just 1 or 2 molecules make it to market - let alone more!

alloa2003
18/12/2021
10:37
Things are happening out there - despite 99% of transactions being sales since the results, the shares have held steady, indeed ticked up a little bit. Listen to the market, the market knows.
alloa2003
17/12/2021
17:04
C4xD still glowing on a sh§@e day !!! Expecting bigGIE news soon
bloomberg2
14/12/2021
16:18
Yes, I thought that as well. I think the fund raising stops them from being shafted by the pharmas if they knew they were desperate for funds, which they arent now.
alloa2003
14/12/2021
15:40
He sounded much more positive than 12 months ago
t0pgrader
14/12/2021
14:55
One other thing to remember - something I keep forgetting. The huge numbers mentioned with some of these deals are ONLY the milestone payments, there are also royalty payments going forward on top (obv they need to be successful). Some of these could be potential £1b+ a year markets.

3% royalties on a billion = £30m a year

6% royalties on a billion = £60m a year

While this is all pie in the sky just now, if the combined market for successful drugs was say £3b a year, even on royalties of 3% that is £90m a year, and that doesnt take into account new molecules, etc in the future.

Did anyone pick up on the fact they are now using their system for gene led treatments? Clive indicated in an interview that when they licence the existing molecule portfolio they need somewhere else to focus. He then suggested along with the ones we know about, with deals and no deals, I think he mentioned another 3 coming through.

He sounded very very positive in my opinion. DYOR

alloa2003
14/12/2021
14:45
The way I have understood this is that, although I could be wrong, the NRF2 deal was expected to be the biggest yet.
alloa2003
14/12/2021
11:07
CD couldn't have been clearer: "in advanced talks" with partners so standby in "the near future" '22 for a deal announcement on NRF2 worth several hundred million $ to the company potentially taking the aggregate value of the three deals to well over $1b.
t0pgrader
13/12/2021
18:24
Thanks t0pgrader
bamboozler
13/12/2021
17:19
Link to results presentation
https://www.c4xdiscovery.com/wp-content/uploads/2021/12/C4XD_Full-Year-Results-Presentation_Dec2021.pdf

t0pgrader
Chat Pages: 114  113  112  111  110  109  108  107  106  105  104  103  Older
Your Recent History
LSE
C4XD
C4x Discov..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20230128 20:36:12